Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

Abstract Background End-stage renal disease (ESRD) patients receiving haemodialysis (HD) are a vulnerable group of patients with increased mortality from COVID-19. Despite improved understanding, the duration of host immunity following COVID-19 infection and role of serological testing alone or in a...

Full description

Bibliographic Details
Main Authors: Olivia Wickens, Rajkumar Chinnadurai, Fahmida Mannan, Frida Svendsen, Mirza Yasar Baig, Chukwuma Chukwu, Ibrahim Ali, Christina Summersgill, Dawn Evans, Berckley V. Antoine, Julie Oxton, Nathan Mairs, Emma Flanagan, Robert Oliver, Philip A. Kalra, Dimitrios Poulikakos
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Nephrology
Subjects:
COVID-19
Antibody testing
Haemodialysis
End-stage renal disease
Online Access:https://doi.org/10.1186/s12882-021-02366-2

Internet

https://doi.org/10.1186/s12882-021-02366-2

Similar Items